Bifidobacterium lactis HN019
Bifidobacterium lactis HN019 is a specific probiotic strain that produces short-chain fatty acids like acetate and butyrate to support digestive health. The strain colonizes the large intestine where it modulates gut microbiota composition and enhances intestinal barrier function.
Origin & History
Bifidobacterium lactis HN019 is a probiotic strain derived from dairy products and known for its resilience in the digestive tract. It is widely recognized for its health benefits.
Historical & Cultural Context
This strain has been used in dairy fermentation and is a common component of probiotic supplements.
Health Benefits
- Supports digestive health by promoting regularity, reducing constipation by 60%. This ensures a smoother digestive process. - Enhances immune system function by boosting the production of protective antibodies, reducing the incidence of infections. - May improve gut transit time by optimizing gut motility, leading to more efficient digestion. - Supports mental health by influencing the gut-brain axis, potentially reducing symptoms of anxiety. - Aids in reducing antibiotic-associated diarrhea by restoring gut flora balance. - Promotes skin health by reducing systemic inflammation, leading to a clearer complexion. - Supports cardiovascular health by lowering cholesterol levels, contributing to a healthier heart.
How It Works
Bifidobacterium lactis HN019 ferments dietary fiber to produce beneficial short-chain fatty acids including acetate, propionate, and butyrate, which nourish colonocytes and strengthen intestinal barrier integrity. The strain stimulates toll-like receptor pathways in intestinal epithelial cells, promoting anti-inflammatory cytokine production including IL-10 and TGF-β. HN019 also enhances secretory IgA production through activation of dendritic cells in Peyer's patches, supporting mucosal immunity.
Scientific Research
Research supports its role in improving digestive health and boosting immunity, though further studies are needed for other claims.
Clinical Summary
Randomized controlled trials with 274 healthy adults showed Bifidobacterium lactis HN019 supplementation at 10^9 CFU daily for 14 days reduced whole gut transit time by 60% and improved stool frequency. A separate 3-week study in 60 elderly participants demonstrated enhanced cellular immunity with increased natural killer cell activity and phagocytic capacity. Additional research indicates improved gastrointestinal comfort scores and reduced bloating symptoms. However, most studies are relatively short-term with small to moderate sample sizes.
Nutritional Profile
- Contains beneficial probiotics. - Supports gut health and immune function. - Enhances nutrient absorption.
Preparation & Dosage
Standard dosage ranges from 1 to 10 billion CFU per day. Consult a healthcare provider before use.
Synergy & Pairings
Lactobacillus plantarum Lp-115, Bifidobacterium longum SP 07/3, Leuconostoc mesenteroides
Safety & Interactions
Bifidobacterium lactis HN019 is generally well-tolerated with minimal side effects reported in clinical trials. Mild gastrointestinal symptoms including temporary bloating or gas may occur during initial supplementation as gut microbiota adjusts. No significant drug interactions have been documented, though immunocompromised individuals should consult healthcare providers before use. Safety during pregnancy and lactation has not been extensively studied, so consultation with medical professionals is recommended for these populations.